Lipoprotein (a) Test

Lipoprotein(a), or Lp(a), is a cholesterol-carrying particle with a genetic component that significantly influences cardiovascular risk. This test measures Lp(a) as a percentage of total lipoprotein, providing insight into your atherogenic lipid profile. High Lp(a) levels are an independent risk factor for heart attack and stroke, even in people with otherwise normal cholesterol. Unlike other lipids, Lp(a) is largely determined by genetics and is less responsive to diet and exercise, making it important for personalized heart disease risk assessment.

Remnant lipoproteins are cholesterol-rich particles that remain after triglycerides are removed from dietary particles in the bloodstream. Elevated remnant lipoprotein levels indicate impaired cholesterol metabolism and are associated with increased cardiovascular risk, independent of traditional cholesterol levels. High remnant lipoproteins suggest metabolic dysfunction, poor diet quality, or genetic predisposition. This test provides insight into heart disease risk beyond standard lipid panels and may warrant lifestyle changes or medication.

Lipoprotein midband B is an uncommon lipoprotein particle detected through specialized lipid testing. Its presence or elevation can indicate certain metabolic disorders or dyslipidemia patterns not visible on standard cholesterol panels. This test is typically ordered when routine lipid results are abnormal or when a patient has unusual cardiovascular risk factors despite normal standard cholesterol levels. Results help refine cardiovascular risk assessment and guide specialized lipid-lowering therapy if needed.